Electroceuticals: Technologies and Global Markets
Report Scope:
This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.
This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.
For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.
This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.
For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 19 data tables and 24 additional tables
- An overview of global markets and technologies for electroceuticals
- Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
- Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
- Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
- Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc, Edwards Lifesciences Corp.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing this Study
What’s New in this Update?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 OVERVIEW
Introduction
Neurostimulation
Cardioverter Defibrillators and Cardiac Pacemakers
Public Access Defibrillators
Battery Technology for Implantable Cardiac Defibrillators
Regulatory Framework
United States
European Union
Japan
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Increasing Incidence of CVD, Neurology and ENT Disorders
Aging Population
Increasing Healthcare Expenditures
Focus on Non-drug Therapies and Reducing Opioid Usage
Technology Innovations and New Product Developments
Market Restraints and Challenges
High Cost of Neurostimulation Procedures/Devices and Lack of Trained Healthcare Professionals
Inconsistent Reimbursement Policies
CHAPTER 5 IMPACT OF COVID-19 PANDEMIC
Introduction
Impact on Neurostimulation Market
Impact on Market for ENT Devices
CHAPTER 6 GLOBAL MARKET FOR ELECTROCEUTICALS BY PRODUCT
Cardioverter Defibrillators and Cardiac Pacemakers
Neurostimulation
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Other Stimulators
Hearing Aids and Implants
Hearing Aid Devices
Behind the Ear
Completely in the Canal
In the Ear
Hearing Implants
Cochlear Implants
Bone Anchored Hearing Implants
Middle Ear Implants
CHAPTER 7 GLOBAL MARKET FOR ELECTROCEUTICALS BY END USER
Hospitals and Clinics
Homecare and Others
CHAPTER 8 GLOBAL MARKET FOR ELECTROCEUTICALS BY REGION
North America
U.S.
Europe
Asia-Pacific
Japan
China
India
Rest of the World
CHAPTER 9 PATENT REVIEW
Introduction
Patents on Hearing Aids and Implants
Neurostimulation
Cardiac
CHAPTER 10 COMPETITIVE LANDSCAPE
Leading Companies in the Market for Neurostimulation Products
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Market for Hearing Aids and Implants by Company
Key Developments
CHAPTER 11 COMPANY PROFILES
ABBOTT LABORATORIES
AXONICS MODULATION TECHNOLOGIES INC.
BIOVENTUS LLC
BIOTRONIK SE & CO. KG
BOSTON SCIENTIFIC CORP.
COCHLEAR AMERICAS
COOK MEDICAL
EDWARDS LIFESCIENCES CORP.
GLAXOSMITHKLINE PLC
LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
LIVANOVA PLC
MEDICO S.P.A.
MEDTRONIC PLC
MICROPORT SCIENTIFIC CORP.
STRYKER CORP.
ZOLL MEDICAL CORP.
CHAPTER 12 APPENDIX: ACRONYMS
Study Goals and Objectives
Reasons for Doing this Study
What’s New in this Update?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 OVERVIEW
Introduction
Neurostimulation
Cardioverter Defibrillators and Cardiac Pacemakers
Public Access Defibrillators
Battery Technology for Implantable Cardiac Defibrillators
Regulatory Framework
United States
European Union
Japan
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Increasing Incidence of CVD, Neurology and ENT Disorders
Aging Population
Increasing Healthcare Expenditures
Focus on Non-drug Therapies and Reducing Opioid Usage
Technology Innovations and New Product Developments
Market Restraints and Challenges
High Cost of Neurostimulation Procedures/Devices and Lack of Trained Healthcare Professionals
Inconsistent Reimbursement Policies
CHAPTER 5 IMPACT OF COVID-19 PANDEMIC
Introduction
Impact on Neurostimulation Market
Impact on Market for ENT Devices
CHAPTER 6 GLOBAL MARKET FOR ELECTROCEUTICALS BY PRODUCT
Cardioverter Defibrillators and Cardiac Pacemakers
Neurostimulation
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Other Stimulators
Hearing Aids and Implants
Hearing Aid Devices
Behind the Ear
Completely in the Canal
In the Ear
Hearing Implants
Cochlear Implants
Bone Anchored Hearing Implants
Middle Ear Implants
CHAPTER 7 GLOBAL MARKET FOR ELECTROCEUTICALS BY END USER
Hospitals and Clinics
Homecare and Others
CHAPTER 8 GLOBAL MARKET FOR ELECTROCEUTICALS BY REGION
North America
U.S.
Europe
Asia-Pacific
Japan
China
India
Rest of the World
CHAPTER 9 PATENT REVIEW
Introduction
Patents on Hearing Aids and Implants
Neurostimulation
Cardiac
CHAPTER 10 COMPETITIVE LANDSCAPE
Leading Companies in the Market for Neurostimulation Products
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Market for Hearing Aids and Implants by Company
Key Developments
CHAPTER 11 COMPANY PROFILES
ABBOTT LABORATORIES
AXONICS MODULATION TECHNOLOGIES INC.
BIOVENTUS LLC
BIOTRONIK SE & CO. KG
BOSTON SCIENTIFIC CORP.
COCHLEAR AMERICAS
COOK MEDICAL
EDWARDS LIFESCIENCES CORP.
GLAXOSMITHKLINE PLC
LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
LIVANOVA PLC
MEDICO S.P.A.
MEDTRONIC PLC
MICROPORT SCIENTIFIC CORP.
STRYKER CORP.
ZOLL MEDICAL CORP.
CHAPTER 12 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table A: Global Market for Electroceuticals, by Product, Through 2027
Table 1: Regulatory Approval: U.S. vs. Europe
Table 2: U.S. FDA Product Classification: Defibrillators
Table 3: U.S. FDA Pacemaker Product Classification
Table 4: U.S. FDA Neurostimulator Product Classification, 2019
Table 5: U.S. FDA Cochlear Implant Product Classification
Table 6: Global Incidence of All Stroke Types, 2019
Table 7: Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 8: Number of Disability-adjusted Life Years (DALYs)for Neurological Disorders and Share of Global DALYs Projected for 2005 and 2030
Table 9: Deaths Attributable to Neurological Disorders, 2005 and 2030
Table 10: World Population, Age 60 and Older, 2000-2050
Table 11: Global Market for Electroceuticals, by Product, 2020-2027
Table 12: Global Market for Cardioverter Defibrillators and Cardiac Pacemakers, by Region, Through 2027
Table 13: Global Market for Spinal Cord Stimulators, by Region, Through 2027
Table 14: Global Market for Deep Brain Stimulators, by Region, Through 2027
Table 15: Global Market for Vagus Nerve Stimulators, by Region, Through 2027
Table 16: Global Market for Other Stimulators, by Region, Through 2027
Table 17: Global Market for Hearing Aids and Implants, by Region, Through 2027
Table 18: Global Market for Electroceuticals, by End User, 2020-2027
Table 19: Global Market for Hospitals and Clinics, by Region, Through 2027
Table 20: Hospitals with Notable Services
Table 21: Global Market for Homecare and Others, by Region, Through 2027
Table 22: Global Market for Electroceuticals, by Region, 2020-2027
Table 23: North American Market for Electroceuticals, by Country, Through 2027
Table 24: Funding by Federal Government for Treatment of Chronic Diseases
Table 25: European Market for Electroceuticals, by Country, Through 2027
Table 26: Asia-Pacific Market for Electroceuticals, by Country, Through 2027
Table 27: China’s Medical Device Regulations
Table 28: Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Table 29: Analysis of Patents Related to Electroceuticals
Table 30: Number of Patents Related to Neurostimulation, by Patent Holder, January 2020 to May 2022
Table 31: Number of Patents Related to Cardiac Stimulation, by Patent Holder, January 2020 to May 2022
Table 32: Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Table 33: Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Table 34: Abbott: Product Portfolio
Table 35: Bioness: Product Information
Table 36: Product Portfolio
Table 37: Medico S.p.A.: Main Products
Table 38: Medico S.p.A.: Recent Developments
Table 39: Medtronic: Product Portfolio
Table 40: MicroPort Scientific Corp.: Product Portfolio
Table 41: Zoll Medical Corp.: Product Portfolio
Table 42: Acronyms Used in This Report
Summary Table A: Global Market for Electroceuticals, by Product, Through 2027
Table 1: Regulatory Approval: U.S. vs. Europe
Table 2: U.S. FDA Product Classification: Defibrillators
Table 3: U.S. FDA Pacemaker Product Classification
Table 4: U.S. FDA Neurostimulator Product Classification, 2019
Table 5: U.S. FDA Cochlear Implant Product Classification
Table 6: Global Incidence of All Stroke Types, 2019
Table 7: Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 8: Number of Disability-adjusted Life Years (DALYs)for Neurological Disorders and Share of Global DALYs Projected for 2005 and 2030
Table 9: Deaths Attributable to Neurological Disorders, 2005 and 2030
Table 10: World Population, Age 60 and Older, 2000-2050
Table 11: Global Market for Electroceuticals, by Product, 2020-2027
Table 12: Global Market for Cardioverter Defibrillators and Cardiac Pacemakers, by Region, Through 2027
Table 13: Global Market for Spinal Cord Stimulators, by Region, Through 2027
Table 14: Global Market for Deep Brain Stimulators, by Region, Through 2027
Table 15: Global Market for Vagus Nerve Stimulators, by Region, Through 2027
Table 16: Global Market for Other Stimulators, by Region, Through 2027
Table 17: Global Market for Hearing Aids and Implants, by Region, Through 2027
Table 18: Global Market for Electroceuticals, by End User, 2020-2027
Table 19: Global Market for Hospitals and Clinics, by Region, Through 2027
Table 20: Hospitals with Notable Services
Table 21: Global Market for Homecare and Others, by Region, Through 2027
Table 22: Global Market for Electroceuticals, by Region, 2020-2027
Table 23: North American Market for Electroceuticals, by Country, Through 2027
Table 24: Funding by Federal Government for Treatment of Chronic Diseases
Table 25: European Market for Electroceuticals, by Country, Through 2027
Table 26: Asia-Pacific Market for Electroceuticals, by Country, Through 2027
Table 27: China’s Medical Device Regulations
Table 28: Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Table 29: Analysis of Patents Related to Electroceuticals
Table 30: Number of Patents Related to Neurostimulation, by Patent Holder, January 2020 to May 2022
Table 31: Number of Patents Related to Cardiac Stimulation, by Patent Holder, January 2020 to May 2022
Table 32: Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Table 33: Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Table 34: Abbott: Product Portfolio
Table 35: Bioness: Product Information
Table 36: Product Portfolio
Table 37: Medico S.p.A.: Main Products
Table 38: Medico S.p.A.: Recent Developments
Table 39: Medtronic: Product Portfolio
Table 40: MicroPort Scientific Corp.: Product Portfolio
Table 41: Zoll Medical Corp.: Product Portfolio
Table 42: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure A: Global Market for Electroceuticals, 2020-2027
Figure 1: Global Deaths from CVD, 2015 and 2030
Figure 2: Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
Figure 3: Global Market for Electroceuticals, by Product, 2020-2027
Figure 4: Pacemakers
Figure 5: Global Market for Electroceuticals, by End User, 2020-2027
Figure 6: Number of Hospitals in the U.S., by Type, 2020
Figure 7: Healthcare Expenditures in the U.S., 2015 and 2025
Figure 8: Trends in Healthcare Spending, by Institution, 2015-2040
Figure 9: North American Market Shares of Electroceuticals, by Country, 2021
Figure 10: European Market Shares of Electroceuticals, by Country, 2021
Figure 11: Asia-Pacific Market Shares of Electroceuticals, by Country, 2021
Figure 12: Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Figure 13: Percentage of Patents on Hearing Aids and Implants, by Country, January 2020 to May 2022
Figure 14: Percentage of Patents on Hearing Aids and Implants, by Patent Holder, January 2020 to May 2022
Figure 15: Percentage of Patents Related to Neurostimulation, by Country, January 2020 to May 2022
Figure 16: Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Figure 17: Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Figure 18: Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 19: Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 20: Abbott: Annual Revenue, 2018–2021
Figure 21: Abbott: Vascular Business Annual Revenue, 2018–2021
Figure 22: Abbott: Revenue Share, by Country, 2021
Figure 23: Boston Scientific: Annual Revenue, 2018–2021
Figure 24: Boston Scientific: Revenue Share, by Business, 2021
Figure 25: Boston Scientific: Revenue Share, by Region, 2021
Figure 26: GlaxoSmithKline plc: Annual Revenue, 2018-2020
Figure 27: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 28: Medtronic: Annual Revenue, 2018–2021
Figure 29: Medtronic Coronary & Peripheral Vascular Segment: Annual Revenue, 2019–2021
Figure 30: Medtronic: Revenue Share, by Region, 2021
Summary Figure A: Global Market for Electroceuticals, 2020-2027
Figure 1: Global Deaths from CVD, 2015 and 2030
Figure 2: Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
Figure 3: Global Market for Electroceuticals, by Product, 2020-2027
Figure 4: Pacemakers
Figure 5: Global Market for Electroceuticals, by End User, 2020-2027
Figure 6: Number of Hospitals in the U.S., by Type, 2020
Figure 7: Healthcare Expenditures in the U.S., 2015 and 2025
Figure 8: Trends in Healthcare Spending, by Institution, 2015-2040
Figure 9: North American Market Shares of Electroceuticals, by Country, 2021
Figure 10: European Market Shares of Electroceuticals, by Country, 2021
Figure 11: Asia-Pacific Market Shares of Electroceuticals, by Country, 2021
Figure 12: Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Figure 13: Percentage of Patents on Hearing Aids and Implants, by Country, January 2020 to May 2022
Figure 14: Percentage of Patents on Hearing Aids and Implants, by Patent Holder, January 2020 to May 2022
Figure 15: Percentage of Patents Related to Neurostimulation, by Country, January 2020 to May 2022
Figure 16: Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Figure 17: Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Figure 18: Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 19: Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 20: Abbott: Annual Revenue, 2018–2021
Figure 21: Abbott: Vascular Business Annual Revenue, 2018–2021
Figure 22: Abbott: Revenue Share, by Country, 2021
Figure 23: Boston Scientific: Annual Revenue, 2018–2021
Figure 24: Boston Scientific: Revenue Share, by Business, 2021
Figure 25: Boston Scientific: Revenue Share, by Region, 2021
Figure 26: GlaxoSmithKline plc: Annual Revenue, 2018-2020
Figure 27: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 28: Medtronic: Annual Revenue, 2018–2021
Figure 29: Medtronic Coronary & Peripheral Vascular Segment: Annual Revenue, 2019–2021
Figure 30: Medtronic: Revenue Share, by Region, 2021
